Biotechnology Industry Analysis
669 companies analyzed • Returns from -503.9% to +483.5% • Data through May 1, 2026
Company List (671 Results)
Industry Performance
(669/669 companies)NKTR
Nektar Therapeutics
CBIO
Crescent Biopharma, Inc.
CUBT
Curative Biotechnology Inc
MRSN
Mersana Therapeutics Inc
SNSE
Sensei Biotherapeutics Inc
RAPT
RAPT Therapeutics Inc
RVMDW
Revolution Medicines, Inc. Warrant
LYEL
Lyell Immunopharma Inc
CUE
Cue Biopharma
STRO
Sutro Biopharma
ATHA
Athira Pharma Inc
FGEN
FibroGen Inc
RLYB
Rallybio Corp
VOR
Vor Biopharma Inc
SPRC
Scisparc Ltd
PTHS
Pelthos Therapeutics Inc.
NXTC
NextCure Inc
RLMD
Relmada Therapeutics Inc
RNAZ
Transcode Therapeutics Inc
PMN
ProMIS Neurosciences Inc.
The Weighted Average return (+28.6%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.
622 companies with market cap data included: NKTR, CBIO, CUBT, MRSN, SNSE, RAPT, LYEL, CUE, STRO, ATHA and 612 more...
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer